Imaging skeletal involvement in Gaucher disease

Advances in Gaucher Disease: Basic and Clinical Perspectives

Volumn , Issue , 2013, Pages 183-200

  Dussen, Laura v a n ^a   Maas, Mario ^a   Hangartner, Thomas N ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Wright State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906924556     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.2217/EBO.13.241     Document Type: Chapter

References (43)

1. Weinreb N, Barranger J, Packman S et al. Imiglucerase (Cerezyme) improves quality of life in patients with skeletal manifestations of Gaucher disease. Clin. Genet. 71(6), 576-588 (2007).
2. Charrow J, Andersson HC, Kaplan P et al. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease. Arch. Intern. Med. 160(18), 2835-2843 (2000).
3. Grabowski GA, Kolodny EH, Weinreb NJ et al. Gaucher disease: phenotypic and genetic variation. In: The Online Metabolic & Molecular Bases of Inherited Disease. Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A (Eds). McGraw-Hill Global Education Holdings, NY, USA (2013).
4. Khan A, Hangartner T, Weinreb NJ et al. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. J. Bone Miner. Res. 27(8), 1839-1848 (2012).
5. Rosenthal DI, Scott JA, Barranger J et al. Evaluation of Gaucher disease using magnetic resonance imaging. J. Bone Joint. Surg. Am. 68(6), 802-808 (1986).
6. Barton NW, Brady RO, Dambrosia JM et al. Replacement therapy for inherited enzyme deficiency - macrophage-targeted glucocerebrosidase for Gaucher's disease. N. Engl. J. Med. 324(21), 1464-1470 (1991).
7. Hollak C, Maas M, Akkerman E et al. Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualized doses of enzyme supplementation therapy in type 1 Gaucher disease. Blood Cells Mol. Dis. 27(6), 1005-1012 (2001).
8. Poll LW, Koch JA, vom Dahl S et al. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme-replacement therapy: first German long term results. Skeletal Radiol. 30(9), 496-503 (2001).
9. Rosenthal DI, Doppelt SH, Mankin HJ et al. Enzyme- replacement therapy for Gaucher disease: skeletal responses to macrophage- targeted glucocerebrosidase. Pediatrics 96(4 Pt 1), 629-637 (1995).
10. Terk MR, Dardashti S, Liebman HA. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume. Skeletal Radiol. 29(10), 563-571 (2000).
11. Maas M, Poll LW, Terk MR. Imaging and quantifying skeletal involvement in Gaucher disease. Br. J. Radiol. 75(Suppl. 1), A13-A24 (2002).
12. El-Beshlawy A, Ragab L, Youssry I et al. Enzyme- replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients. J. Inherit. Metab. Dis. 29(1), 92-98 (2006).
13. Hermann G, Goldblatt J, Levy RN et al. Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy. AJR Am. J. Roentgenol. 147(5), 943-948 (1986).
14. Maas M, van Kuijk C, Stoker J et al. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging - initial experience. Radiology 229(2), 554-561 (2003).
15. Poll LW, Cox ML, Godehardt E et al. Whole body MRI in type I Gaucher patients: evaluation of skeletal involvement. Blood Cells Mol. Dis. 46(1), 53-59 (2011).
16. Smith JJ, Sorensen AG, Thrall JH. Biomarkers in imaging: realizing radiology's future. Radiology 227(3), 633-638 (2003).
17. vom Dahl S, Poll L, Di Rocco M et al. Evidence-based recommendations for monitoring bone disease and the response to enzyme- replacement therapy in Gaucher patients. Curr. Med. Res. Opin. 22(6), 1045-1064 (2006).
18. Dixon WT. Simple proton spectroscopic imaging. Radiology 153(1), 189-194 (1984).
19. Johnson LA, Hoppel BE, Gerard EL et al. Quantitative chemical shift imaging of vertebral bone marrow in patients with Gaucher disease. Radiology 182(2), 451-455 (1992).
20. Maas M, Akkerman EM, Venema HW et al. Dixon quantitative chemical shift MRI for bone marrow evaluation in the lumbar spine: a reproducibility study in healthy volunteers. J. Comput. Assist. Tomogr. 25(5), 691-697 (2001).
21. Maas M, Hollak CE, Akkerman EM et al. Quantification of skeletal involvement in adults with type I Gaucher's disease: fat fraction measured by Dixon quantitative chemical shift imaging as a valid parameter. AJR Am. J. Roentgenol. 179(4), 961-965 (2002).
22. Rosen BR, Fleming DM, Kushner DC et al. Hematologic bone marrow disorders: quantitative chemical shift MR imaging. Radiology 169(3), 799-804 (1988).
23. Wismer GL, Rosen BR, Buxton R et al. Chemical shift imaging of bone marrow: preliminary experience. AJR Am. J. Roentgenol. 145(5), 1031-1037 (1985).
24. Tran SD, Terk MR, Colletti PM. Proton MR spectroscopy of bone marrow: precision and reliability. AJR Am. J. Roentgenol. 174(3 Suppl.), 60 (2000).
25. Lanir A, Hadar H, Cohen I et al. Gaucher disease: assessment with MR imaging. Radiology 161(1), 239-244 (1986).
26. Magnaldi S, Longo R, Ukmar M et al. Bone marrow relaxation times in Gaucher disease before and after enzyme- replacement therapy. Eur. Radiol. 7(4), 486-491 (1997).
27. Vlieger EJ, Maas M, Akkerman EM et al. Vertebra disc ratio as a parameter for bone marrow involvement and its application in Gaucher disease. J. Comput. Assist. Tomogr. 26(5), 843-848 (2002).
28. DeMayo RF, Haims AH, McRae MC etal. Correlation of MRI-based bone marrow burden score with genotype and spleen status in Gaucher's disease. AJR Am. J. Roentgenol. 191(1), 115-123 (2008).
29. Robertson PL, Maas M, GoldblattJ. Semiquantitative assessment of skeletal response to enzyme- replacement therapy for Gaucher's disease using the bone marrow burden score. AJR Am. J. Roentgenol. 188(6), 1521-1528 (2007).
30. El Maghraoui A, Roux C. DXA scanning in clinical practice. QJM 101(8), 605-617 (2008).
31. Adams JE. Quantitative computed tomography. Eur. J. Radiol. 71(3), 415-424 (2009).
32. Lang TF, Guglielmi G, van Kuijk C et al. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy x-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30(1), 247-250 (2002).
33. Goodsitt MM, Rosenthal DI, Reinus WR et al. Two postprocessing CT techniques for determining the composition of trabecular bone. Invest. Radiol. 22(3), 209-215 (1987).
34. Israel O, Jerushalmi J, Front D. Scintigraphic findings in Gaucher's disease. J. Nucl. Med. 27(10), 1557-1563 (1986).
35. Aharoni D, Krausz Y, Elstein D et al. Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease. Clin. Nucl. Med. 27(7), 503-509 (2002).
36. Katz R, Booth T, Hargunani R et al. Radiological aspects of Gaucher disease. Skeletal Radiol. 40(12), 1505-1513 (2011).
37. Roca M, Mota J, Alfonso P et al. S-MRI score: a simple method for assessing bone marrow involvement in Gaucher disease. Eur. J. Radiol. 62(1), 132-137 (2007).
38. Maas M, Hollak CE, Akkerman EM et al. Radiology of Gaucher disease (type 1) and bone manifestations: the Dutch experience. JBR-BTR 89(6), 318-321 (2006).
39. Vanhoenacker FM, Maas M. Guidelines for Belgian MR centers for monitoring of bone marrow involvement in patients with Gaucher disease. JBR-BTR 89(6), 321-324 (2006).
40. Weinreb NJ, Aggio MC, Andersson HC et al. Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients. Semin. Hematol. 41(4 Suppl. 5), 15-22 (2004).
41. Niederau C, Rolfs A, vom Dahl S et al. [Diagnosis and therapy of Gaucher disease. current recommendations of German therapy centers in the year 2000]. Med. Klin. (Munich) 96(1), 32-39 (2001).
42. Hermann G, Shapiro RS, Abdelwahab IF et al. MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity. Skeletal Radiol. 22(4), 247-251 (1993).
43. Terk MR, Esplin J, Lee K et al. MR imaging of patients with type 1 Gaucher's disease: relationship between bone and visceral changes. AJR Am. J. Roentgenol. 165(3), 599-604 (1995).